Jonathan S Cebon

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
 
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Jackson, Heather M
Author:  Davis, Ian D
Date Issued:  [2000 TO 2009]
Subject:  Middle Aged

Results 1-4 of 4 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
110-Mar-2009Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.Nicholaou, Theo; Ebert, Lisa M; Davis, Ian D; McArthur, Grant A; Jackson, Heather M; Dimopoulos, Nektaria; Tan, Bee; Maraskovsky, Eugene; Miloradovic, Lena; Hopkins, Wendie; Pan, Linda; Venhaus, Ralph; Hoffman, Eric W; Chen, Weisan; Cebon, Jonathan S 
210-Sep-2006Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.Davis, Ian D; Chen, Qiyuan; Morris, Leone; Quirk, Juliet; Stanley, Maureen; Tavarnesi, Maria L; Parente, Phillip; Cavicchiolo, Tina; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin Yee; MacGregor, Duncan; Browning, Judy; Svobodova, Suzanne; Caron, Dania; Maraskovsky, Eugene; Old, Lloyd J; Chen, Weisan; Cebon, Jonathan S 
315-May-2006Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.Jackson, Heather M; Dimopoulos, Nektaria; Mifsud, Nicole A; Tai, Tsin Yee; Chen, Qiyuan; Svobodova, Suzanne; Browning, Judy; Luescher, Immanuel F; Stockert, Lisa; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
423-Sep-2004The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.Shackleton, Mark; Davis, Ian D; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin; Chen, Qiyuan; Parente, Phillip; Jefford, Michael; Masterman, Kelly-Anne; Caron, Dania; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S